SV2008002648A - Peptidos y compuestos que se unen a un receptor ref. tdp5001svnp - Google Patents

Peptidos y compuestos que se unen a un receptor ref. tdp5001svnp

Info

Publication number
SV2008002648A
SV2008002648A SV2006002648A SV2006002648A SV2008002648A SV 2008002648 A SV2008002648 A SV 2008002648A SV 2006002648 A SV2006002648 A SV 2006002648A SV 2006002648 A SV2006002648 A SV 2006002648A SV 2008002648 A SV2008002648 A SV 2008002648A
Authority
SV
El Salvador
Prior art keywords
compounds
peptides
join
receiver
ref
Prior art date
Application number
SV2006002648A
Other languages
English (en)
Inventor
Brian R Macdonald
Jeffery Kenneth Weis
Edward John Yurkow
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37734435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2008002648(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of SV2008002648A publication Critical patent/SV2008002648A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN COMPUESTOS PEPTÍDICOS QUE SE UNEN Y ACTIVAN EL RECEPTOR DE TROMBOPOYETINA (C-MPL O TPO-R) O DE OTRO MODO ACTÚAN COMO AGONISTA DE TPO
SV2006002648A 2005-08-09 2006-08-09 Peptidos y compuestos que se unen a un receptor ref. tdp5001svnp SV2008002648A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/200,416 US7723295B2 (en) 2003-08-28 2005-08-09 Peptides and compounds that bind to a receptor

Publications (1)

Publication Number Publication Date
SV2008002648A true SV2008002648A (es) 2008-11-28

Family

ID=37734435

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2006002648A SV2008002648A (es) 2005-08-09 2006-08-09 Peptidos y compuestos que se unen a un receptor ref. tdp5001svnp

Country Status (35)

Country Link
US (1) US7723295B2 (es)
EP (1) EP1957517B1 (es)
JP (1) JP2009504650A (es)
KR (1) KR20080048026A (es)
CN (1) CN101287749A (es)
AR (1) AR055114A1 (es)
AU (1) AU2006280230B2 (es)
BR (1) BRPI0614647A2 (es)
CA (1) CA2618958A1 (es)
CR (1) CR9798A (es)
CY (1) CY1114032T1 (es)
DK (1) DK1957517T3 (es)
EA (1) EA200800535A1 (es)
EC (1) ECSP088169A (es)
ES (1) ES2419005T3 (es)
GT (1) GT200600361A (es)
HK (1) HK1123811A1 (es)
HR (1) HRP20130518T1 (es)
IL (1) IL189361A (es)
JO (1) JO2859B1 (es)
MY (1) MY152177A (es)
NI (1) NI200800040A (es)
NO (1) NO344405B1 (es)
NZ (1) NZ565497A (es)
PE (1) PE20070416A1 (es)
PL (1) PL1957517T3 (es)
PT (1) PT1957517E (es)
RS (1) RS52802B (es)
SI (1) SI1957517T1 (es)
SV (1) SV2008002648A (es)
TW (1) TWI400081B (es)
UA (1) UA96418C2 (es)
UY (1) UY29736A1 (es)
WO (1) WO2007021572A2 (es)
ZA (1) ZA200802184B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
AU2003275077B2 (en) 2002-09-18 2010-02-04 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
EP1986677A2 (en) * 2006-01-25 2008-11-05 Amgen Inc. Thrombopoietic compounds
MX2010013281A (es) * 2008-06-03 2010-12-21 Janssen Pharmaceutica Nv Peptido mimetico de trombopoyetina para prevenir trastornos hematologicos asociados con el tratamiento del cancer.
JP5709113B2 (ja) * 2011-06-23 2015-04-30 株式会社島津製作所 分岐型両親媒性ブロックポリマー、それを用いた分子集合体及び薬剤搬送システム
BR112020001367A2 (pt) 2017-07-26 2020-08-11 Janssen Pharmaceutica N.V. métodos de proteção da integridade vascular induzida por terapia de radiação direcionada
CA3127455A1 (en) 2019-01-25 2020-07-30 Janssen Pharmaceutica Nv Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments
US11273203B2 (en) 2019-01-25 2022-03-15 Janssen Pharmaceutica Nv Methods of mitigating toxic effects of vesicants and caustic gas
WO2020154637A1 (en) 2019-01-25 2020-07-30 Janssen Pharmaceutica Nv Methods of enhancing protection against organ and vascular injury, hematopoietic recovery and survival in response to total body radiation/chemical exposure
US20230104658A1 (en) 2021-10-01 2023-04-06 Janssen Pharmaceutica Nv Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5326558A (en) * 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5571508A (en) 1989-12-18 1996-11-05 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
IT1241395B (it) 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
ATE222500T1 (de) 1992-06-11 2002-09-15 Alkermes Inc Enythropoietin enthaltendes arzneimittelabgabesystem
EP0945504A3 (en) * 1992-12-11 1999-12-08 The University Of Florida Materials and method for control of pests
WO1995011922A1 (en) 1993-10-29 1995-05-04 Affymax Technologies N.V. In vitro peptide and antibody display libraries
SG47030A1 (en) 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
NZ281482A (en) 1994-02-14 2000-09-29 Univ Washington The stimulation of erythropoiesis using thrombopoietin and erythropoietin
WO1995021919A2 (en) 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
NZ271230A (en) 1994-02-14 1998-03-25 Zymogenetics Inc Hematopoietic proteins, production and use
SG79882A1 (en) 1994-02-14 2001-04-17 Kirin Brewery Protein having tpo activity
DK0690127T3 (da) 1994-03-31 1999-05-03 Amgen Inc Sammensætninger og fremgangsmåder til stimulering af megakaryocytvækst og -differentiering
US5571686A (en) 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
WO1996017062A1 (en) 1994-11-30 1996-06-06 Zymogenetics, Inc. Low molecular weight thrombopoietin
ES2276401T3 (es) 1995-04-26 2007-06-16 Kyowa Hakko Kogyo Co., Ltd. Proteinas de fusion g-csf tpo.
ES2303338T3 (es) 1995-06-07 2008-08-01 Glaxo Group Limited Peptidos y compuestos que se unen a un receptor de trombopoyetina.
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
AU771460B2 (en) 1999-09-24 2004-03-25 Smithkline Beecham Corporation Thrombopoietin mimetics
WO2002078612A2 (en) 2001-04-02 2002-10-10 Euro-Celtique S.A. Thrombopoietin (tpo) synthebody for stimulation of platelet production
AU2003275077B2 (en) * 2002-09-18 2010-02-04 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
RS56387B1 (sr) * 2003-08-28 2017-12-29 Ortho Mcneil Pharm Inc Peptidi i jedinjenja koja se vežu za trombopoetinski receptor

Also Published As

Publication number Publication date
UA96418C2 (ru) 2011-11-10
HK1123811A1 (en) 2009-06-26
MY152177A (en) 2014-08-15
UY29736A1 (es) 2006-12-29
RS52802B (en) 2013-10-31
EA200800535A1 (ru) 2008-08-29
JP2009504650A (ja) 2009-02-05
AR055114A1 (es) 2007-08-08
CA2618958A1 (en) 2007-02-22
JO2859B1 (en) 2015-03-15
GT200600361A (es) 2007-03-14
AU2006280230A1 (en) 2007-02-22
TW200744626A (en) 2007-12-16
KR20080048026A (ko) 2008-05-30
NO20081298L (no) 2008-04-23
IL189361A (en) 2015-11-30
PE20070416A1 (es) 2007-06-13
EP1957517A2 (en) 2008-08-20
BRPI0614647A2 (pt) 2011-04-12
NI200800040A (es) 2010-11-25
WO2007021572A3 (en) 2007-06-07
CR9798A (es) 2008-09-09
ECSP088169A (es) 2008-03-26
PL1957517T3 (pl) 2013-08-30
CY1114032T1 (el) 2016-07-27
SI1957517T1 (sl) 2013-07-31
DK1957517T3 (da) 2013-04-08
PT1957517E (pt) 2013-05-28
US7723295B2 (en) 2010-05-25
HRP20130518T1 (hr) 2013-07-31
ES2419005T3 (es) 2013-08-19
ZA200802184B (en) 2009-08-26
US20060040866A1 (en) 2006-02-23
TWI400081B (zh) 2013-07-01
NO344405B1 (no) 2019-12-02
EP1957517B1 (en) 2013-03-20
CN101287749A (zh) 2008-10-15
IL189361A0 (en) 2008-06-05
AU2006280230B2 (en) 2012-11-08
WO2007021572A2 (en) 2007-02-22
NZ565497A (en) 2011-10-28

Similar Documents

Publication Publication Date Title
SV2008002648A (es) Peptidos y compuestos que se unen a un receptor ref. tdp5001svnp
ECSP066396A (es) Peptidos y compuestos que se unen a un receptor
LTC2380592I2 (lt) Antagonistinis antikūnas, nukreiptas prieš su kalcitonino genu susijusį peptidą
TNSN07264A1 (en) Organic compounds
CY1113188T1 (el) Τροποποιημενα fgf-21 πολυπεπτιδια και οι χρησεις τους
EA200702643A1 (ru) Антитела, связывающие tweak
DK1749921T3 (da) Brandhæmmende, syntetisk læder
GB0503434D0 (en) Amyloid-binding peptides, analogues and uses thereof
TW200736190A (en) Emitting materials and organic light emitting device using the same
ATE509944T1 (de) Peptidische vasopressin-rezeptoragonisten
EA201000258A1 (ru) Новые гербициды
WO2010048588A3 (en) Directed engagement of activating fc receptors
NO20053147L (no) Forsterkningsring.
ATE410428T1 (de) Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonisten
ATE399089T1 (de) Verbundbauteil mit strukturiertem wolframteil
CR8300S (es) Recipiente para ajo
NL1028090A1 (nl) Aanvoertransporteur.
FR2887764B1 (fr) Bouteille, telle qu'un biberon, et bague de serrage integree a cette bouteille
IT1391013B1 (it) Agenti estinguenti a base di miscele di fluoroiodo-carburi additivati con composti detossificanti.
ES1055866U (es) Mopa-fregona.
ES1058250Y (es) Protector de ropa.
CY1115531T1 (el) Αντισωματα συνδεσης tweak
UY29620A1 (es) Polimorfos de hidrocodona
ES1059948Y (es) Transportador de bisectrices.
ES1060524Y (es) Manguera.

Legal Events

Date Code Title Description
FD Lapse